SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-12-056665
Filing Date
2012-08-09
Accepted
2012-08-09 18:18:15
Documents
1
Period of Report
2012-08-07

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4229
  Complete submission text file 0001104659-12-056665.txt   5580
Mailing Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703
Business Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703 919 474 0020
TRANZYME INC (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 4819 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address
Davidson Aaron (Reporting) CIK: 0001515825 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 121021870